Idera Pharmaceuticals, Inc.
Simbol: IDRA
NASDAQ
0.425
USDTržna cena danes
-97.1145
Razmerje P/E
7.8442
Razmerje PEG
26.50M
Kapaciteta MRK
- 0.00%
Donos DIV
Idera Pharmaceuticals, Inc. (IDRA) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 65.44 | 12 | 32.5 | 37.7 | ||||||||||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 4.5 | ||||||||||||||||||||||||||||
balance-sheet.row.net-receivables | 8.38 | 4.2 | 0 | 0 | ||||||||||||||||||||||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 5.35 | 1.6 | 1.5 | 3.6 | ||||||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 79.16 | 17.9 | 34 | 41.4 | ||||||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 2.27 | 0.5 | 0.8 | 1 | ||||||||||||||||||||||||||||
balance-sheet.row.goodwill | 25.66 | 11.1 | 0 | 0 | ||||||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 201.67 | 71.6 | 0 | 0 | ||||||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 227.33 | 82.7 | 0 | 0 | ||||||||||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0.82 | 0 | 0.1 | 0.1 | ||||||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 230.43 | 83.2 | 0.8 | 1 | ||||||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||
balance-sheet.row.total-assets | 309.59 | 101.1 | 34.9 | 42.4 | ||||||||||||||||||||||||||||
balance-sheet.row.account-payables | 15.52 | 5.2 | 0.6 | 0.3 | ||||||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 0.92 | 0.2 | 0.2 | 0.2 | ||||||||||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 1.42 | 0.3 | 0.5 | 0.8 | ||||||||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 10.19 | - | - | - | ||||||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 46.81 | 16 | 4.1 | 6.5 | ||||||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 142.95 | 40.8 | 0.5 | 126.5 | ||||||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 2.33 | 0.6 | 0.8 | 0.9 | ||||||||||||||||||||||||||||
balance-sheet.row.total-liab | 206.21 | 62.2 | 5.4 | 133.6 | ||||||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 55.2 | 34.3 | 0 | 0 | ||||||||||||||||||||||||||||
balance-sheet.row.common-stock | 0.12 | 0 | 0.1 | 0 | ||||||||||||||||||||||||||||
balance-sheet.row.retained-earnings | -3032.5 | -758.8 | -735.5 | -833.6 | ||||||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -0.02 | 0 | 0 | 0 | ||||||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 3053.47 | 736.4 | 764.9 | 742.3 | ||||||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 76.27 | 11.8 | 29.5 | -91.2 | ||||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 282.48 | 74 | 34.9 | 42.4 | ||||||||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||
balance-sheet.row.total-equity | 76.27 | 11.8 | 29.5 | -91.2 | ||||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 282.48 | - | - | - | ||||||||||||||||||||||||||||
Total Investments | 0 | 0 | 0 | 4.5 | ||||||||||||||||||||||||||||
balance-sheet.row.total-debt | 2.33 | 0.6 | 0.8 | 0.9 | ||||||||||||||||||||||||||||
balance-sheet.row.net-debt | -63.1 | -11.5 | -31.8 | -32.3 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -41.05 | -23.4 | 98.1 | -112.7 | |||||||||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0.01 | 0 | 0 | 0.1 | |||||||||||||||||||||||||||||
cash-flows.row.deferred-income-tax | -0.27 | -6.3 | 0 | 0 | |||||||||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 2.2 | 2.5 | 3.6 | |||||||||||||||||||||||||||||
cash-flows.row.change-in-working-capital | -0.86 | 0.3 | 0.4 | -1.1 | |||||||||||||||||||||||||||||
cash-flows.row.account-receivables | 2 | -2.3 | 0 | 0 | |||||||||||||||||||||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||
cash-flows.row.account-payables | -2.74 | 2.5 | -1.8 | -1.6 | |||||||||||||||||||||||||||||
cash-flows.row.other-working-capital | 1.7 | -0.3 | 2.1 | 0.5 | |||||||||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 9.52 | 2.7 | -125.6 | 76.3 | |||||||||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -29.78 | 0 | 0 | 0 | |||||||||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | -12.2 | |||||||||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 4.5 | 10.5 | |||||||||||||||||||||||||||||
cash-flows.row.other-investing-activites | 5.48 | 5.5 | 0 | 0 | |||||||||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 5.48 | 5.5 | 4.5 | -1.7 | |||||||||||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | -0.2 | |||||||||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0.2 | 28.8 | |||||||||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||
cash-flows.row.other-financing-activites | -1.58 | -1.5 | 19.3 | 0.1 | |||||||||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -1.58 | -1.5 | 19.4 | 28.7 | |||||||||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||
cash-flows.row.net-change-in-cash | -25.88 | -20.5 | -0.7 | -6.8 | |||||||||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 65.44 | 12 | 32.5 | 33.2 | |||||||||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 91.31 | 32.5 | 33.2 | 40 | |||||||||||||||||||||||||||||
cash-flows.row.operating-cash-flow | -29.78 | -24.5 | -24.6 | -33.8 | |||||||||||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||
cash-flows.row.free-cash-flow | -29.78 | -24.5 | -24.6 | -33.8 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 5.67 | 0 | 0 | 0 | |||||||||||||||||||||||||||||
income-statement-row.row.gross-profit | -5.67 | 0 | 0 | 0 | |||||||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||
income-statement-row.row.research-development | 15.4 | - | - | - | |||||||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 14.73 | - | - | - | |||||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||||||||
income-statement-row.row.other-expenses | 28.55 | 8.3 | 1.3 | 0 | |||||||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 51.58 | 32.7 | 27.7 | 36.7 | |||||||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 57.25 | 32.7 | 27.7 | 36.7 | |||||||||||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0.2 | |||||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 0.02 | 0.2 | 0 | 0 | |||||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -0.02 | -0.2 | 0 | -76 | |||||||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 28.55 | 8.3 | 1.3 | 0 | |||||||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | -0.02 | -0.2 | 0 | -76 | |||||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 0.02 | 0.2 | 0 | 0 | |||||||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 1.71 | 1.7 | 0 | 0.1 | |||||||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | -45.91 | - | - | - | |||||||||||||||||||||||||||||
income-statement-row.row.operating-income | -47.62 | -29.5 | 98.1 | -36.7 | |||||||||||||||||||||||||||||
income-statement-row.row.income-before-tax | -47.64 | -29.7 | 98.1 | -112.7 | |||||||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | -6.59 | -6.3 | 0 | -76 | |||||||||||||||||||||||||||||
income-statement-row.row.net-income | -41.05 | -23.4 | 98.1 | -112.7 |
Pogosto zastavljeno vprašanje
Kaj je Idera Pharmaceuticals, Inc. (IDRA) skupna sredstva?
Idera Pharmaceuticals, Inc. (IDRA) skupna sredstva so 101107000.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so -49000.000.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 58.878.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je -0.003.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je 665.265.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so 680.245.
Kaj je Idera Pharmaceuticals, Inc. (IDRA) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je -23360000.000.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 560000.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 32680000.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 2118000.000.